Chinnapaiyan S, Santiago M, Panda K, Rahman M, Alluin J, Rossi J
Mol Ther Nucleic Acids. 2023; 32:553-565.
PMID: 37215150
PMC: 10192333.
DOI: 10.1016/j.omtn.2023.04.011.
Behmardi A, Farazmandfar T
Drug Deliv Transl Res. 2022; 12(10):2561-2568.
PMID: 35098492
DOI: 10.1007/s13346-021-01109-y.
Yin L, Zhao F, Sun H, Wang Z, Huang Y, Zhu W
Mol Ther Nucleic Acids. 2020; 21:147-155.
PMID: 32585623
PMC: 7321785.
DOI: 10.1016/j.omtn.2020.05.030.
Bajan S, Hutvagner G
Cells. 2020; 9(1).
PMID: 31936122
PMC: 7016530.
DOI: 10.3390/cells9010137.
Bala J, Chinnapaiyan S, Kumar Dutta R, Unwalla H
RNA Biol. 2018; 15(3):327-337.
PMID: 29431588
PMC: 5927724.
DOI: 10.1080/15476286.2017.1414131.
Knockdown and replacement therapy mediated by artificial mirtrons in spinocerebellar ataxia 7.
Curtis H, Seow Y, Wood M, Varela M
Nucleic Acids Res. 2017; 45(13):7870-7885.
PMID: 28575281
PMC: 5569705.
DOI: 10.1093/nar/gkx483.
HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus.
Chinnapaiyan S, Parira T, Dutta R, Agudelo M, Morris A, Nair M
PLoS One. 2017; 12(1):e0169161.
PMID: 28060951
PMC: 5217953.
DOI: 10.1371/journal.pone.0169161.
Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.
Farazmandfar T, Haghshenas M, Shahbazi M
Hum Gene Ther. 2015; 26(10):680-7.
PMID: 26077977
PMC: 4630793.
DOI: 10.1089/hum.2015.031.
HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
Daniels S, Sinck L, Ward N, Melendez-Pena C, Scarborough R, Azar I
RNA Biol. 2015; 12(2):123-35.
PMID: 25668122
PMC: 4615856.
DOI: 10.1080/15476286.2015.1014759.
Establishing Restricted Expression of Caveolin-1 in HIV Infected Cells and Inhibition of Virus Replication.
Lo Y, Nadeau P, Lin S, Mergia A
Open Microbiol J. 2014; 8:114-21.
PMID: 25408776
PMC: 4235073.
DOI: 10.2174/1874285801408010114.
Selection of RNAi-based inhibitors for anti-HIV gene therapy.
Knoepfel S, Centlivre M, Liu Y, Boutimah F, Berkhout B
World J Virol. 2013; 1(3):79-90.
PMID: 24175213
PMC: 3782270.
DOI: 10.5501/wjv.v1.i3.79.
Artificial mirtron-mediated gene knockdown: functional DMPK silencing in mammalian cells.
Seow Y, Sibley C, Wood M
RNA. 2012; 18(7):1328-37.
PMID: 22647847
PMC: 3383964.
DOI: 10.1261/rna.030601.111.
RNAi and small interfering RNAs in human disease therapeutic applications.
Lares M, Rossi J, Ouellet D
Trends Biotechnol. 2010; 28(11):570-9.
PMID: 20833440
PMC: 2955826.
DOI: 10.1016/j.tibtech.2010.07.009.
A dual function TAR Decoy serves as an anti-HIV siRNA delivery vehicle.
Unwalla H, Rossi J
Virol J. 2010; 7:33.
PMID: 20144240
PMC: 2836314.
DOI: 10.1186/1743-422X-7-33.
Toward a durable anti-HIV gene therapy based on RNA interference.
Berkhout B
Ann N Y Acad Sci. 2009; 1175:3-14.
PMID: 19796072
PMC: 7167650.
DOI: 10.1111/j.1749-6632.2009.04972.x.
Simultaneous knockdown of the expression of two genes using multiple shRNAs and subsequent knock-in of their expression.
Xu X, Yoo M, Carlson B, Gladyshev V, Hatfield D
Nat Protoc. 2009; 4(9):1338-48.
PMID: 19713955
PMC: 2753455.
DOI: 10.1038/nprot.2009.145.
Activity of TAR in inducible inhibition of HIV replication by foamy virus vector expressing siRNAs under the control of HIV LTR.
Park J, Nadeau P, Mergia A
Virus Res. 2008; 140(1-2):112-20.
PMID: 19110017
PMC: 2683472.
DOI: 10.1016/j.virusres.2008.11.016.
Maintaining the silence: reflections on long-term RNAi.
Raemdonck K, Vandenbroucke R, Demeester J, Sanders N, De Smedt S
Drug Discov Today. 2008; 13(21-22):917-31.
PMID: 18620073
PMC: 7108305.
DOI: 10.1016/j.drudis.2008.06.008.
Tat-regulated expression of RNA interference: triggers for the treatment of HIV infection.
Unwalla H, Rossi J
Curr HIV/AIDS Rep. 2008; 5(1):40-3.
PMID: 18417034
PMC: 2703456.
DOI: 10.1007/s11904-008-0007-3.
Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition.
Brake O, Hooft K, Liu Y, Centlivre M, Jasmijn von Eije K, Berkhout B
Mol Ther. 2008; 16(3):557-64.
PMID: 18180777
PMC: 7172400.
DOI: 10.1038/sj.mt.6300382.